Lucid Diagnostics Inc. is a publicly traded corporate entity listed on the Nasdaq stock exchange under the ticker symbol LUCD, meaning it is collectively owned by institutional asset management firms, mutual fund investment houses, corporate insiders, and public retail shareholders. It operates as a commercial-stage subsidiary originally spun out of PAVmed Inc. to advance early-stage cancer prevention technologies.